Filing Details
- Accession Number:
- 0001127602-19-009277
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-01 17:45:17
- Reporting Period:
- 2019-02-28
- Accepted Time:
- 2019-03-01 17:45:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
64803 | Cvs Health Corp | CVS | Retail-Drug Stores And Proprietary Stores (5912) | 050494040 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1757584 | David James Clark | One Cvs Drive Woonsocket RI 02895 | Svp, Cont & Chief Acct Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-02-28 | 288 | $57.83 | 8,557 | No | 4 | F | Direct | |
Common Stock (Restricted) | Acquisiton | 2019-02-28 | 1,323 | $57.83 | 9,088 | No | 4 | A | Direct | |
Common Stock | Disposition | 2019-03-01 | 1,664 | $58.14 | 6,893 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-03-01 | 1,664 | $45.07 | 8,557 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2019-03-01 | 1,664 | $0.00 | 1,664 | $45.07 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-04-02 | 2019-04-02 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | $54.53 | 2014-04-01 | 2020-04-01 | 3,030 | 3,030 | Direct |
Common Stock | Stock Option | $74.29 | 2015-04-01 | 2021-04-01 | 5,350 | 5,350 | Direct |
Common Stock | Stock Option | $102.26 | 2016-04-01 | 2022-04-01 | 6,059 | 6,059 | Direct |
Common Stock | Stock Option | $104.82 | 2017-04-01 | 2023-04-01 | 7,044 | 7,044 | Direct |
Common Stock | Stock Option | $78.05 | 2018-04-03 | 2024-04-03 | 9,050 | 9,050 | Direct |
Common Stock | Stock Option | $62.21 | 2019-04-01 | 2025-04-01 | 7,513 | 7,513 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2020-04-01 | 3,030 | 3,030 | Direct |
2021-04-01 | 5,350 | 5,350 | Direct |
2022-04-01 | 6,059 | 6,059 | Direct |
2023-04-01 | 7,044 | 7,044 | Direct |
2024-04-03 | 9,050 | 9,050 | Direct |
2025-04-01 | 7,513 | 7,513 | Direct |
Footnotes
- Surrender of shares in payment of withholding taxes due upon the vesting of stock awards under the Issuer's 2017 Incentive Compensation Plan..
- Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan and its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2020.
- Remaining Options became exercisable in four equal annual installments beginning on 4/2/2013.
- Remaining Options became exercisable in four equal annual installments beginning on 4/1/2014.
- Remaining Options became exercisable in four equal annual installments beginning on 4/1/2015.
- Options became exercisable in four equal annual installments beginning on 4/1/2016.
- Options became exercisable in four equal annual installments beginning on 4/1/2017.
- Options became exercisable in four equal annual installments beginning on 4/3/2018.
- Options become exercisable in four equal annual installments, commencing 4/1/2019.